Oral antifungal therapy for oral and oropharyngeal candidiasis in adults

Oral antifungal therapy is recommended for adults with severe oropharyngeal candidiasis (eg multiple or confluent lesions, swallowing difficulties), or oral and oropharyngeal candidiasis that does not respond to topical antifungal therapy. Medical practitioners can usePappas, 2016:

If patients do not improve on oral therapy, obtain swabs for microscopy, culture and susceptibility testing, and consider Oesophageal candidiasisKeighley, 2021. For advice on systemic antifungal therapy for adults with HIV infection, see Oropharyngeal candidiasis in adults with HIV infection.